Outside formal IPC guidance, between 2013-2016 scientists were uncovering how everyday human activity generates infectious aerosols in indoor spaces, a finding with direct consequences for hospital transmission.
Using high-speed imaging, Lydia Bourouiba (MIT fluid dynamics) and colleagues showed that coughs, sneezes and speech produce turbulent gas clouds that generate fine aerosols capable of remaining suspended in shared air.
(JAMA 2014; NEJM 2016)
In parallel, Donald Milton (aerosol scientist & infectious disease researcher) demonstrated that infectious aerosols are produced during normal breathing NOT ONLY during coughing or symptomatic events.
These findings overturned a core assumption of infection control: that exhaled particles either fall quickly to surfaces or dissipate at close range.
Instead, aerosols could persist and accumulate within indoor air.
If aerosols were generated by normal breathing (Milton) and persisted in shared air (Bourouiba), then close-contact infection models were fundamentally flawed.
The droplet–aerosol distinction was no longer theoretical, it was operational.
By 2016, aerosol transmission in hospitals was no longer speculative.
Yet Exercise Cygnus fixed UK pandemic planning to the wrong transmission model and IPC guidance then enforced it.
🧵 THREAD: The quiet revolution in aerosol transmission (2017–2019)
In the years just before COVID, scientists were increasingly clear that “droplet vs airborne” was a false binary and that real-world transmission didn’t fit it.
Across epidemiology, virology, and aerosol science, researchers were synthesising evidence from influenza, SARS-1, measles, and TB that challenged droplet-based infection models.
Scientists including Linsey Marr, Lidia Morawska, Julian Tang, Tellier, and Zeynep Tufekci were making this case publicly in papers, commentaries, and outbreak analyses.
I’ll cover their work in individual profile tweets.
How do aerosol viruses like SARS-CoV-2 spread in hospital settings? 🧵
Understanding airborne transmission is essential to preventing hospital-acquired COVID.
Aerosols are tiny particles released when people breathe, speak, cough, or shout.
Unlike droplets, aerosols can remain suspended in the air, travel beyond close contact, and accumulate indoors.
In hospitals, risk increases when:
• ventilation is inadequate
• air changes are low
• spaces are crowded
• patients and staff share air for prolonged periods
This is especially true on wards.